Achieve Life Sciences clinical trials we track

Check company identity source

Phase 3 5 trials

Phase 2 1 trial

TrialDrugs studiedStatusPrimary completion
A Study of Cytisinicline for Vaping Cessation in Adult SmokersNCT05431387Behavioral support, cytisiniclineCompleted2023-02-28Actual

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 6 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Overall Survival. After: Measure: Overall Survival: All Randomized Population Measure: Overall Survival: Stratified by Histology - Squamous vs. Non-Squamous.

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 700 participants (planned). After: 664 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Jul 2017. After: 17 Nov 2016.

Recruitment status changed

Before: Recruiting. After: Completed.

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Proportion of Participants With Smoking Abstinence During the Last 4 Weeks of 6 Weeks Cytisinicline Treatment Versus Placebo Treatment (Wk 3-6) Measure: Proportion of Participants With Smoking Abstinence During the Last 4 Weeks of 12 Weeks Cytisinicline Treatment Versus Placebo Treatment (Wk 9-12). After: Measure: Percentage of Participants With Smoking Abstinence From Weeks 3 to Week 6 Measure: Percentage of Participants With Smoking Abstinence From Weeks 9 to Week 12.

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Proportion of Participants With Vaping Abstinence During Weeks 9 to 12. After: Measure: Percentage of Participants With Vaping Abstinence From Week 9 to 12.

Check registry source

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 650 participants (planned). After: 479 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 31 Dec 2025. After: 29 Sep 2025.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source